FOXM1 and gastric cancer: Besides the well-known signaling pathways that FOXM1 and PLAU involved in, our results also indicate that FOXM1 and PLAU may participate in the JAK-STAT3, DNA repair and drug resistance (Docetaxel and Doxorubicin) in GC.